AstraZeneca plc vs NetApp Inc. — how do they compare? AstraZeneca plc trades at $158.42 (market cap $248.14B), while NetApp Inc. trades at $199.79 (market cap $38.95B). The key difference: AstraZeneca plc is far larger — about 6.4× NetApp Inc.'s market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | NTAP | |
|---|---|---|
Market Cap | $248.14B | $38.95B |
Sector | Health | Technology |
52-Week High | $209.48 | $198.72 |
52-Week Low | $147.06 | $94.11 |
Enterprise Value | $275.41B | $38.10B |
Dividend Yield | 2.01% | 1.05% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →